SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-020277
Filing Date
2020-07-23
Accepted
2020-07-23 21:04:47
Documents
1
Period of Report
2020-07-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3404
  Complete submission text file 0000899243-20-020277.txt   5260
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Reporting) CIK: 0001121404 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39397 | Film No.: 201044870
SIC: 2834 Pharmaceutical Preparations

Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Issuer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations